Arrowstreet Capital
SCMP

Arrowstreet Capital’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Arrowstreet Capital’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-56,415
Closed -$975K – 1682
2015
Q4 		$975K Buy
56,415
+35,200
+166% +$631K ﹤0.01% 998
2015
Q3 		$422K Buy
+21,215
New +$486K ﹤0.01% 1128
2014
Q1 		– Sell
-23,955
Closed -$225K – 1455
2013
Q4 		$225K Buy
+23,955
New +$171K ﹤0.01% 1093
2013
Q3 		– Sell
-14,672
Closed -$97K – 1173
2013
Q2 		$97K Buy
+14,672
New +$116K ﹤0.01% 774

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Arrowstreet Capital's SCMP Position: Q1 2016 in Review

Arrowstreet Capital sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2016, closing a stake of 56,415 shares — an estimated $975K sold.

Arrowstreet Capital first reported a position in SCMP in Q2 2013 and held it in 4 quarters. The position peaked at $975K in Q4 2015. 134 funds tracked by Wall St. Rank hold SCMP as of Q1 2016.

  • Arrowstreet Capital reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Arrowstreet Capital sold 56,415 Sucampo Pharmaceuticals, Inc. shares in Q1 2016, an estimated $975K.
  • Arrowstreet Capital first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
  • Arrowstreet Capital's Sucampo Pharmaceuticals, Inc. position peaked at $975K in Q4 2015.
  • 134 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2016.

Based on Arrowstreet Capital's 13F filing for Q1 2016, filed 16 May 2016.